What Happened?
Valencia, CA-based Avita-Medical Appointed David O`Toole as Chief Financial Officer
About the Company
Avita Medical is a publicly listed regenerative medicine company trading on the Australian Stock Exchange (ASX:AVH) and OTC Markets (OTCQX:AVMXY). The company`s lead product, ReCell® is used in a wide variety of burns, chronic wounds, plastic, reconstructive and cosmetic procedures. ReCell is patented, CE-marked for Europe, TGA- registered in Australia, and SFDA-cleared in China. ReCell is not available for sale in the United States; in the US ReCell is an investigational device limited by federal law to investigational use.
About the Person
David O`Toole is Chief Financial Officer at Avita Medical. Previously, David held various senior HR leadership roles in the industry.
Info Source
Press Release
Short Profile